Literature DB >> 17141903

Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer.

Uulke A van der Heide1, Alexis N T J Kotte, Homan Dehnad, Pieter Hofman, Jan J W Lagenijk, Marco van Vulpen.   

Abstract

PURPOSE: Evaluate the fiducial marker-based position verification in the external-beam radiotherapy of patients with prostate cancer.
METHODS: Four hundred and fifty-three patients with prostate cancer received an IMRT treatment combined with fiducial marker-based position verification. Portal images were taken in all 35 treatment fractions. This database was used to study the accuracy of detecting the prostate position as well as the presence of time trends and the effectiveness of commonly used off-line correction protocols.
RESULTS: The variation in inter-marker distance shows that the prostate position can be detected with an accuracy better than 0.6 mm. Significant time trends in prostate position occurred in 35%, 18% and 48% of the patients in the vertical, lateral and longitudinal directions, respectively, with 34%, 9% and 35% deviating more than 3 mm over the course of the treatment. Off-line correction protocols that estimate a deviation only in the first fractions of the treatment (shrinking action level (SAL), no action level (NAL)) are not effective in following these trends. With daily off-line position correction using an adapted SAL protocol we reduced systematic positioning errors in clinical practice to less than 0.8 mm in all directions.
CONCLUSION: Fiducial markers are a reliable tool for prostate position verification. Time trends occur frequently. Correction procedures must take such trends into account.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141903     DOI: 10.1016/j.radonc.2006.11.002

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  33 in total

1.  Uncertainties and CTV to PTV margins quantitative assessment using cone-beam CT technique in clinical application for prostate, and head and neck irradiation tumours.

Authors:  X J Juan-Senabre; J López-Tarjuelo; A Conde-Moreno; A Santos-Serra; A L Sánchez-Iglesias; J D Quirós-Higueras; N de Marco Blancas; S Calzada-Feliu; C Ferrer-Albiach
Journal:  Clin Transl Oncol       Date:  2011-11       Impact factor: 3.405

Review 2.  Technological advances in radiation therapy for prostate cancer.

Authors:  Mehee Choi; Arthur Y Hung
Journal:  Curr Urol Rep       Date:  2010-05       Impact factor: 3.092

3.  Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.

Authors:  Ruggero Ruggieri; Stefania Naccarato; Pavel Stavrev; Nadejda Stavreva; Sergio Fersino; Niccolò Giaj Levra; Rosario Mazzola; Pietro Mancosu; Marta Scorsetti; Filippo Alongi
Journal:  Br J Radiol       Date:  2015-08-03       Impact factor: 3.039

4.  Effect of magnesium oxide on interfraction prostate motion and rectal filling in prostate cancer radiotherapy: analysis of a randomized clinical trial.

Authors:  Annemarie M den Harder; Carla H van Gils; Alexis N T J Kotte; Marco van Vulpen; Irene M Lips
Journal:  Strahlenther Onkol       Date:  2014-04-24       Impact factor: 3.621

5.  Comparison of a simple dose-guided intervention technique for prostate radiotherapy with existing anatomical image guidance methods.

Authors:  G Smyth; H M McCallum; M J M Pearson; G P Lawrence
Journal:  Br J Radiol       Date:  2011-03-08       Impact factor: 3.039

6.  Modeling positioning uncertainties of prostate cancer external beam radiation therapy using pre-treatment data.

Authors:  Per Munck af Rosenschöld; Neil B Desai; Jung Hun Oh; Aditya Apte; Margie Hunt; Abraham Kalikstein; James Mechalakos; Laura Happersett; Joseph O Deasy; Michael J Zelefsky
Journal:  Radiother Oncol       Date:  2014-02-20       Impact factor: 6.280

7.  Comparison of prostate positioning guided by three-dimensional transperineal ultrasound and cone beam CT.

Authors:  Minglun Li; Hendrik Ballhausen; Nina-Sophie Hegemann; Michael Reiner; Stefan Tritschler; Christian Gratzke; Farkhad Manapov; Stefanie Corradini; Ute Ganswindt; Claus Belka
Journal:  Strahlenther Onkol       Date:  2016-12-07       Impact factor: 3.621

Review 8.  Fiducial marker guided prostate radiotherapy: a review.

Authors:  Angela G M O'Neill; Suneil Jain; Alan R Hounsell; Joe M O'Sullivan
Journal:  Br J Radiol       Date:  2016-09-23       Impact factor: 3.039

9.  Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers.

Authors:  David Skarsgard; Pat Cadman; Ali El-Gayed; Robert Pearcey; Patricia Tai; Nadeem Pervez; Jackson Wu
Journal:  Radiat Oncol       Date:  2010-06-10       Impact factor: 3.481

10.  Reduction of margins in external beam radiotherapy.

Authors:  Tomas Kron
Journal:  J Med Phys       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.